KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $17.8 billion.

  • Eli Lilly's Receivables - Net rose 6136.65% to $17.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $17.8 billion, marking a year-over-year increase of 6136.65%. This contributed to the annual value of $17.8 billion for FY2025, which is 6136.65% up from last year.
  • As of Q4 2025, Eli Lilly's Receivables - Net stood at $17.8 billion, which was up 6136.65% from $16.1 billion recorded in Q3 2025.
  • In the past 5 years, Eli Lilly's Receivables - Net registered a high of $17.8 billion during Q4 2025, and its lowest value of $5.6 billion during Q1 2021.
  • For the 5-year period, Eli Lilly's Receivables - Net averaged around $9.1 billion, with its median value being $7.7 billion (2023).
  • Its Receivables - Net has fluctuated over the past 5 years, first soared by 334.49% in 2022, then soared by 6136.65% in 2025.
  • Over the past 5 years, Eli Lilly's Receivables - Net (Quarter) stood at $6.7 billion in 2021, then increased by 3.34% to $6.9 billion in 2022, then surged by 31.82% to $9.1 billion in 2023, then increased by 21.07% to $11.0 billion in 2024, then soared by 61.37% to $17.8 billion in 2025.
  • Its last three reported values are $17.8 billion in Q4 2025, $16.1 billion for Q3 2025, and $14.2 billion during Q2 2025.